On-Demand Virtual Care Reinvented

Claim My Business
Security Type
Common Stock
Min Investment
Offering Date
November 12, 2021
Expected Close Date
February 08, 2022
Target Raise
No. Investors
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Company Description

XRHealth Virtual Clinics offer at-home medical and therapeutic treatments through Virtual Reality (VR/AR) and digital health technologies. XRHealth integrates immersive VR/AR technology, licensed clinicians, and advanced data analytics on one platform, providing a comprehensive therapeutic care solution for patients to receive treatment from the comfort of their home.

Key Deal Facts

XRHealth unlocked a distribution channel and revenue cycle for VR/AR technology, and is demonstrating strong revenue growth: XRHealth has generated over $1 million in revenue, and treated over 2,000 patients in Q1-Q3 of 2021and is showing 60% growth in revenue QoQ. With $20M raised to date, from crowdfunding, Angel investors, AARP and VCs, Including $4M in grants, with this new funding round, we believe we'll be able to continue to maintain this growth trajectory.
Unique Technology in a Large Market: The fast-growing Telehealth Market is predicted to reach a value of $70.19 billion by 2026. Combining XRHealth VR/AR Medical technology and generating valuable objective data points, allows telehealth clinicians to tailor individualized treatment plans for each patient and modify over the course of therapy. Our VR/AR telehealth technology is protected by 21 patents submitted by XRHealth, out of which 3 have been approved, 14 published and 4 pending.
Patient Satisfaction and Clinical Outcomes We have strong patient satisfaction, evidenced by XRHealth NPS (Net Promoter Score) of 74 (vs healthcare market average of 38) with 72% of patients agreeing we made a positive difference in their symptoms in under two weeks.

Management Team / Advisory Board Bios

Hillel Bachrach
Board of Directors
Entrepreneur with more than 40 years of experience managing and funding the commercial global introduction of innovative and revolutionary medical and life science technologies. After a successful career as an entrepreneur starting many companies that were either sold or went public, in 2005 Hillel founded 20/20 HealthCare Partners, an investment company where he is the Managing Partner.

Eran Orr
CEO, Founder & Director
During a 15-year career as an F-16 fighter pilot in the Israeli Air Force and several executive positions, Eran has established himself as a worldwide leader in the XR and health industries and is an official Forbes Councils Member.

Gilad Meiri
Board of Directors
Gilad is a serial entrepreneur and active angel investor. He currently acts as a board member and the CFO of Cupixel. Before that Gilad founded and was the CEO of Neura (acquired by Otonomo Technologies) and Spicebox Labs. Gilad is also a director in publicly traded Third Eye Systems (TASE: THES).

Miki Levy
CTO & Co-Founder
During a 16-year career as an executive officer in the Israeli Air Force Miki received the IDF Major General's Award of Excellence. Miki serves as the president of the VR/AR Association, Tel Aviv chapter.

Deepa Javeri
Chief Financial Officer
During a 15-year career in financial services ranging from equity portfolio management at Merrill Lynch to M&A banking at Morgan Stanley, Deepa developed broad expertise in capital markets, financial planning, and corporate strategy.

Gal Hayut
Board of Directors
After more than 13 years at the Venture Capital Industry and 4 years as the Managing Director of The Portland Trust Israel, a nonprofit 'action-tank" that leads economic development projects in the undeserved population in Israel, Gal recently established Bridges Israel, together with his two partners. Bridges Israel an impact investments fund that invest in businesses that operate among the underserved population in Israel as well as in "tech-for good" Start-ups

Sergey Gribov
Board of Directors
Technology entrepreneur and investor with more than 20 years of experience. Sergey has a lot of experience across such sectors as software development, VoIP, cybersecurity, digital health, finance, and others.
Today Sergey is an investor, board member, or mentor in several startups across US and Israel.
Sergey holds an MBA, Sloan Fellow from MIT and B.Sc. in Computer Science, Cum Laude from Beer-Sheva University.
Amount Raised : $274,379
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter